![]() |
市場調查報告書
商品編碼
1324867
膽紅素測量儀器市場:現狀分析與預測(2022-2028)Bilirubin Meter Market: Current Analysis and Forecast (2022-2028) |
膽紅素測量儀器市場預計在預測期內將以 6% 的複合年增長率增長。識別新生兒黃疸的診斷工具。這是由於新生兒黃疸發生率增加,以及8週前出生的新生兒黃疸發生率增加所致。例如,根據《2022 年國家衛生服務報告》,妊娠 37 週之前的早產嬰兒中,每 10 名就有 6 名出現黃疸,其中每 10 名嬰兒就有 8 名出現黃疸。此外,與黃疸發生相關的危險因素包括器械助產、催產素引產、嬰兒破裂和其他醫療狀況。因此,所有這些因素預計將在預測期內推動市場增長。
按產品分,市場分為便攜式膽紅素計和台式膽紅素計。其中,便攜式膽紅素測量設備預計在預測期內將以顯著的複合年增長率增長。便攜式膽紅素測量儀通常體積小、重量輕,因此易於攜帶並在各種環境中使用,包括醫院、診所和家庭醫療保健。通常從指尖或腳後跟抽取少量血液,用於測量膽紅素水平。因此,這一因素有助於該細分市場的增長。
按最終用戶劃分,市場分為醫院、診所和研究機構。其中,醫院行業預計在預測期內將以較大的複合年增長率增長。醫院在黃疸和肝炎等肝臟疾病的早期發現和治療方面發揮著重要作用,有助於預防嚴重並發症。此外,優質醫院擁有必要的醫療設備和人員,能夠為多種病情的患者提供全面的護理,減輕醫療保健系統的整體負擔。這些因素正在推動對醫院的需求。
預計亞太地區在預測期內將以顯著的複合年增長率增長。這是由於該地區醫療保健支出增加。例如,2021財年支付給醫療機構的醫療保健支出創下歷史新高,達到316萬億美元,比上年增加14萬億美元(4.6%)。這正在推動該地區的市場增長。
Bilirubin meters are devices designed for the measurement of the concentration of bilirubin present in the blood or clinical specimen there are several types of bilirubin meters, including those that use spectroscopy, turbidity and impedance. The level of bilirubin should be interpreted in conjunction with other laboratory results and clinical findings. A high level of bilirubin can be a sign of a number of conditions including haemolytic anaemia, liver disease and neonatal jaundice. On the contrary, lower levels of bilirubin may be seen in patients taking antibiotics or may be due to other medical conditions including Gilbert's syndrome.
The bilirubin meter Market is anticipated to grow with a CAGR of 6% in the forecasted period. The diagnostic tools for the identification of neonatal jaundice. This is attributed to the rising incidence of jaundice amongst the neonates along with those neonates who are born before 8 weeks. For instance, according to the national health service 2022 report, around 6 out of 10 babies born develop jaundice including 8 out of 10 who are born prematurely before 37 weeks of pregnancy. Additionally, the risk factors associated with the development of jaundice include instrumental deliveries, induction of labour with oxytocin, infant bursting and other medical conditions. Thus, all these factors are anticipated to fuel the market growth in the forecast period.
Based on the product, the market is bifurcated into portable bilirubinometers and benchtop bilirubinometers. Amongst these, the portable bilirubinometer is anticipated to grow with a significant CAGR in the forecasted period. These are typically small and lightweight, making them easy to carry and use in a variety of settings, including hospitals, clinics, and home care settings. They use a small amount of blood, typically from a fingertip or heel stick, to measure the level of bilirubin. Thus, this factor is contributing towards the growth of this segment.
Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Hospitals play a crucial role in the early detection and management of liver disease, including jaundice and hepatitis which can help prevent severe complications of diseases. Additionally, hospitals are equipped with the necessary medical equipment and staff to provide comprehensive care to patients with a wide range of medical conditions and reduce the overall burden of the disease on the healthcare system. These elements are driving the demand for the hospitals
For a better understanding of the market adoption of the Behavior Health industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. Asia-pacific is anticipated to grow with a significant CAGR during the forecasted period. This is attributed to the increase in healthcare expenditure in this region. For instance, healthcare expenditures paid to medical institutions in fiscal 2021 reached a record USD 316 trillion, an increase of 14 trillion, or 4.6%, compared to the previous year. This is propelling the market growth in this region.
Some of the major players operating in the market include: Advanced Instruments Inc., APEL Co., Ltd., Siemens Medical Solutions USA, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Dragerwerk AG & Co. KGaA, Zhengzhou Dison Instrument and Meter Co., ltd. , Mennen Medical, Natus Medical Incorporated., DAVID, Micro Lab Instruments.